- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03635307
Ability of Changes in End Tidal Carbon Dioxide to Assess the Stroke Volume Effects of a Volume Expansion of 250ml of Crystalloid in the Operating Room (REVCO2)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main objective of volume expansion is to increase stroke volume. Franck-Starling curve is schematically divided into two portions: a vertical portion which mean that an increase in preload secondary to volume expansion will induce an increase in stroke volume; and a flat portion which mean that a same increase in preload will not induce an increase in stroke volume. Perioperative optimization is based on stroke volume maximization using volume expansion. Despite national and international recommendations, stroke volume monitoring is clearly not widely adopted. This is mostly due to the cost and the invasiveness of the devices allowing stroke volume monitoring. End tidal carbon dioxide is monitored in all patients undergoing general anaesthesia and is totally non-invasive. Several studies evaluated the relationship between stroke volume and end tidal carbon dioxide and other studies evaluated the ability of changes in end tidal carbon dioxide to assess changes in stroke volume induced by volume expansion with discordant results. These studies included small sample size and were heterogeneous (intensive care unit and nor operating room, volume expansion or passive leg raising, crystalloid or colloid, 500ml and not 250 ml ….). Nowadays, it is not clear if changes in end tidal carbon dioxide can be considered as a surrogate of changes in stroke volume during a volume expansion in operating room patients. Thus, the aim of the present study is to determine if change in End Tidal Carbon Dioxide can assess the stroke volume effects of a volume expansion of 250ml of crystalloid in the operating room.
The follow up will be restricted to the duration of volume expansion. The last data will be collected just after the end of volume expansion.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France
- CHU de Bordeaux
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient older than 18 years
- Scheduled for neurosurgery in prone position
- Equipped from an arterial catheter and stroke volume monitoring
Exclusion Criteria:
Patient with cardiac dysfunction and/or lung disease
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Operated patients with volume expansion
|
End Tidal Carbon Dioxide measures before and after a volume expansion of 250ml of crystalloid in the operating room.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
End Tidal Carbon Dioxide measure
Time Frame: Beggining time of volume expansion of 250ml of crystalloid during surgery
|
Beggining time of volume expansion of 250ml of crystalloid during surgery
|
End Tidal Carbon Dioxide measure
Time Frame: 1 minute after the end of volume expansion of 250ml of crystalloid during surgery
|
1 minute after the end of volume expansion of 250ml of crystalloid during surgery
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2018/18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Volume Expansion
-
University Hospital, BordeauxCompletedVolume Expansion | Left Ventricular ContractilityFrance
-
University Hospital, BordeauxCompletedFluid Responsiveness | Volume ExpansionFrance
-
Xijing HospitalFirst Affiliated Hospital Xi'an Jiaotong UniversityUnknown
-
Medical University of South CarolinaAmerican Association of Orthodontics FoundationRecruiting
-
University of BaghdadNot yet recruitingMaxillary Expansion
-
University of L'AquilaCompletedPalatal Expansion TechniqueItaly
-
Medical University of ViennaNot yet recruiting
-
University Hospital, LinkoepingCompleted
-
University of Wisconsin, MadisonNot yet recruitingBreast Reconstruction | Tissue ExpansionUnited States
-
Hospital for Special Surgery, New YorkCompletedBlood Volume AnalysisUnited States
Clinical Trials on End Tidal Carbon Dioxide measure
-
Seoul National University HospitalRecruiting
-
SMG-SNU Boramae Medical CenterUnknownVentilation Perfusion Mismatch
-
Tanta UniversityCompletedShock | Fluid Responsiveness | End Tidal Carbon Dioxide | CardiometryEgypt
-
Peking Union Medical College HospitalUnknown
-
University of MichiganCompleted
-
Hospital Universitario GetafeCompletedCorrelation Between Exhaled Carbon Dioxide and in Arterial BloodSpain
-
Spire, Inc.Clinimark, LLCCompleted
-
Emory UniversityWithdrawnCardiovascular Disease | Heart Disease | CardiomyopathyUnited States
-
Inonu UniversityCompletedMorbid Obesity | Bariatric Surgery Candidate | Hemodynamic InstabilityTurkey
-
Newcastle-upon-Tyne Hospitals NHS TrustUnknownRespiratory Distress Syndrome in Premature Infants | Extreme Prematurity - Less Than 28 WeeksUnited Kingdom